Similar articles for PMID: 36241216

Year	Number of Results
1978	2
1983	1
1984	1
1987	1
1990	1
1991	2
1992	1
1994	1
1995	3
1998	2
1999	2
2000	1
2002	1
2003	2
2005	4
2006	4
2007	3
2008	4
2009	4
2010	3
2011	5
2012	8
2013	9
2014	12
2015	14
2016	12
2017	10
2018	10
2019	12
2020	11
2021	6
2022	11
2023	9
2024	3

1

Tolerance Interval Approach for the Determination of Overfill of Liquid Parenteral Drug Products.

Schmelzer B, Sutter M. Schmelzer B, et al. PDA J Pharm Sci Technol. 2023 May-Jun;77(3):181-196. doi: 10.5731/pdajpst.2022.012743. Epub 2022 Oct 14. PDA J Pharm Sci Technol. 2023. PMID: 36241216

2

A Predictive Modeling Approach to Support the Overfill Volume Definition of Liquid-in-Vial Drug Products.

Dasnoy S, Simonin L, Radulovic S, White A, Decoster JF, Denis L. Dasnoy S, et al. PDA J Pharm Sci Technol. 2022 Sep-Oct;76(5):384-394. doi: 10.5731/pdajpst.2021.012658. Epub 2022 Jan 14. PDA J Pharm Sci Technol. 2022. PMID: 35031540

3

Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.

4

Relationship between drain volume/fill volume ratio and clinical outcomes associated with overfill complaints in peritoneal dialysis patients.

Davis ID, Cizman B, Mundt K, Wu L, Childers R, Mell R, Prichard S. Davis ID, et al. Perit Dial Int. 2011 Mar-Apr;31(2):148-53. doi: 10.3747/pdi.2010.00012. Epub 2011 Jan 31. Perit Dial Int. 2011. PMID: 21282375 Review.

5

Prescription of Controlled Substances: Benefits and Risks.

Preuss CV, Kalava A, King KC. Preuss CV, et al. 2023 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30726003 Free Books & Documents.

6

Investigation of often-reported ten percent hysteroscopy fluid overfill: is this accurate?

Nezhat CH, Fisher DT, Datta S. Nezhat CH, et al. J Minim Invasive Gynecol. 2007 Jul-Aug;14(4):489-93. doi: 10.1016/j.jmig.2007.03.007. J Minim Invasive Gynecol. 2007. PMID: 17630169 Clinical Trial.

7

Simple Approach to Calculate Random Effects Model Tolerance Intervals to Set Release and Shelf-Life Specification Limits of Pharmaceutical Products.

Montes RO, Burdick RK, Leblond DJ. Montes RO, et al. PDA J Pharm Sci Technol. 2019 Jan-Feb;73(1):39-59. doi: 10.5731/pdajpst.2018.008839. Epub 2018 Oct 25. PDA J Pharm Sci Technol. 2019. PMID: 30361286

8

Tissue Expander Overfilling: Achieving New Dimensions of Customization in Breast Reconstruction.

Treiser MD, Lahair T, Carty MJ. Treiser MD, et al. Plast Reconstr Surg Glob Open. 2016 Feb 5;4(2):e612. doi: 10.1097/GOX.0000000000000594. eCollection 2016 Feb. Plast Reconstr Surg Glob Open. 2016. PMID: 27014541 Free PMC article.

9

Closed System Transfer Devices (CSTDs): Understanding Potential Over- and Under- Dosing of Liquid Vial Drug Products and How to Generally Mitigate.

Lehermayr C, Schmelzer B, Kropf M. Lehermayr C, et al. J Pharm Sci. 2023 Sep;112(9):2532-2537. doi: 10.1016/j.xphs.2023.04.014. Epub 2023 May 3. J Pharm Sci. 2023. PMID: 37146755

10

Semiquantitative sensitization safety assessment of extractable and leachables associated with parenteral pharmaceutical products.

Liu F, Hutchinson RW. Liu F, et al. Regul Toxicol Pharmacol. 2023 Feb;138:105335. doi: 10.1016/j.yrtph.2023.105335. Epub 2023 Jan 4. Regul Toxicol Pharmacol. 2023. PMID: 36608924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

150 results

Results by year